{"id":106544,"date":"2023-03-24T15:06:58","date_gmt":"2023-03-24T14:06:58","guid":{"rendered":"http:\/\/es\/biomaterials-for-neural-regeneration\/"},"modified":"2026-01-16T13:48:56","modified_gmt":"2026-01-16T12:48:56","slug":"biomaterials-for-neural-regeneration","status":"publish","type":"page","link":"https:\/\/ibecbarcelona.eu\/es\/research-groups\/biomaterials-for-neural-regeneration\/","title":{"rendered":"Biomaterials for Neural Regeneration"},"content":{"rendered":"
\n

ABOUT<\/h2>\n
\n\n\n\n\n

The inability of the central nervous system (CNS) to regenerate has been attributed to several factors: First, the natural formation of cellular \u00abbridges\u00bb essential for axonal regeneration does not occur at the site of injury. Second, the injured CNS fails to produce growth factors necessary to stimulate regeneration. Third, neurons in the injured CNS do not adequately initiate a \u00abgrowth program\u00bb necessary for new regeneration. Finally, the environment of the injured adult spinal cord presents obstacles to regeneration, specifically due to inhibitory extracellular matrix molecules that accumulate around the injury site and the presence of inhibitory proteins in adult myelin that hinder regeneration.<\/h4>\n\n\n\n
\n

We are committed to elucidating the molecular processes underlying neuronal regeneration and using these insights to develop practical strategies for repairing damaged CNS circuits. <\/p>\n<\/blockquote>\n\n\n\n

Our research covers a broad spectrum from the identification of ECM molecules that impede axon regeneration to the development and application of advanced biomimetic materials in spinal cord injury (SCI) models.<\/p>\n\n\n\n

Our group is interested in elucidating the molecular mechanisms governing regenerative failure after central nervous system injury and leveraging this knowledge to develop rationally tuned biomaterial strategies to reverse paralysis. Our goal is to translate these findings to humans.<\/p>\n\n\n\n

<\/div>\n\n\n\n

RESEARCH FOCUS<\/strong><\/p>\n\n\n\n

Understanding the Barriers to Regeneration:<\/strong><\/strong><\/p>\n\n\n\n

The primary focus of this research is to understand the role of the extracellular matrix (ECM) in spinal cord injury and regeneration. <\/p>\n\n\n\n

\n
\n

Using quantitative mass spectrometry proteomics, our team is characterizing the ECM and ECM-associated proteome in spinal cords across developmental stages and injury conditions. This approach allows the identification of specific ECM components that change after injury, providing insight into potential therapeutic targets. <\/p>\n\n\n\n

The comprehensive proteomic profile is further enhanced by transcriptomic profiling to identify soluble components, cellular contributors, and spatial information. This in-depth analysis of the ECM in both healthy and injured states aims to unravel the complex interactions and changes that occur and to guide the development of strategies to modulate the ECM to promote regeneration<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n
Human spinal motor neurons grown on artificial matrix<\/strong>. SEM image of neurons interacting through their growth cones. Cells are falsely colored in green and purple.<\/em><\/pre>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
New tools to study injury and regeneration in vitro:<\/strong><\/p>\n\n\n\n
This research area uses cutting-edge bioengineering methods and three-dimensional systems to mimic spinal cord structures and analyze their responses to injury in the laboratory. It uses two primary techniques:<\/p>\n\n\n\n
1. Human Spinal Cord Organoids (hSCOs)<\/em>: hSCOs are generated using 3D printed organoid-on-a-chip technology, which creates a tubular shape that mimics the geometry of the spinal cord. This structure allows us to study how the shape of the tissue affects cellular organization within the organoids. In addition, by incorporating ECM signals at specific times after spinal cord injury, the study aims to explore the evolving nature of spinal cord injury and evaluate treatments based on ECM components identified through this research.<\/p>\n\n\n\n
2. 3D printed human spinal cord constructs<\/em>: This method combines two sophisticated printing technologies – cell bioprinting and volumetric printing – to produce a detailed, four-dimensional model of the human spinal cord with precise accuracy. The focus is on faithfully reproducing the white and gray matter of the spinal cord. It uses an exoskeletal framework to strategically place each bioprinted cell, closely mimicking the architecture of the spinal cord. This approach is designed to provide insight into the dynamic functional behavior of the spinal cord in vitro.<\/p>\n\n\n\n
<\/p>\n<\/div>\n<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
Translational Strategies for the Treatment of Spinal Cord Injury:<\/strong><\/p>\n\n\n\n
The third area of our research focuses on the development of innovative and effective biomaterial-based therapies for spinal cord injury (SCI) using in vivo models. Our team is implementing two different approaches depending on the stage of injury:<\/p>\n\n\n\n
\n
\n
1. Injectable functionalized synthetic hydrogels for acute injury<\/em>: We are creating chemically defined hydrogels that mimic various ECM signals, specifically tailored to treat the early stages of spinal cord injury. The goal is to study their impact on factors such as inflammation, cell survival, blood vessel formation, glial scar formation, and nerve fiber regeneration<\/p>\n<\/div>\n\n\n\n
\n
\n